My question patchspike is the comparison between each companies point of time difference, and the importance of revenue inflowing to WBT heading forward as WBT reach full qualification with Skywater.
The impact on the shareprice for BRN with a lack of revenue over the past 12-18 months is a valid comparison.
WBT have no revenue currently. But we are hopefully about to begin
If WBT dont deliver on revenue soon, hopefully not, we trend that way.
Its all about revenue now and customer signings, thats why I ask the question about WBT and BRNs chart comparison now from surfguy.
- Forums
- ASX - By Stock
- WBT
- Charts
Charts, page-3961
-
- There are more pages in this discussion • 1,029 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WBT (ASX) to my watchlist
|
|||||
Last
$2.51 |
Change
0.000(0.00%) |
Mkt cap ! $474.1M |
Open | High | Low | Value | Volume |
$2.55 | $2.56 | $2.50 | $658.3K | 260.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $2.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.53 | 3114 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 2.510 |
7 | 21146 | 2.500 |
2 | 601 | 2.490 |
5 | 29928 | 2.480 |
4 | 6156 | 2.470 |
Price($) | Vol. | No. |
---|---|---|
2.530 | 3114 | 2 |
2.550 | 5443 | 2 |
2.560 | 4824 | 2 |
2.580 | 3181 | 2 |
2.590 | 24003 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
WBT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online